biotech

graph

Analyst Has 2 Biotech Stocks to Buy With at Least 100% Upside Potential

Needless to say, the biotech world has had a very difficult year. Even the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, have suffered ...
Read Full Story »
Female patient on gurney

Why Minerva’s Incredible Move May Be Justified

Minerva Neurosciences Inc. (NASDAQ: NERV) saw its shares make absolutely massive gains on Thursday following the release of positive results from a couple mid-stage clinical trials. Specifically the company announced ...
Read Full Story »
mosquito

7 Companies in the Fight to Defeat the Zika Virus

In 2016, it is the Zika virus that has the public worried about the next pandemic. Past scares have been around Ebola, E. coli, SARS, mad cow, swine flu and ...
Read Full Story »
IPO

Selecta Biosciences Files for IPO

Selecta Biosciences has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were listed in the filing, but the offering ...
Read Full Story »
clinical trials

Why Sarepta’s PDUFA Delay Is a Good Thing

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares saw a handy gain on Wednesday following an analyst upgrade. Janney Montgomery Scott has a Neutral rating on Sarepta but increased its fair value estimate to ...
Read Full Story »
child with cancer

Cellectar Wins Big on New Patent

Cellectar Biosciences Inc. (NASDAQ: CLRB) watched its shares skyrocket on Wednesday morning following the announcement of a patent. The company announced that it has obtained a patent that covers CLR 1603, ...
Read Full Story »
Female patient on gurney

5 Major Clinical Trial Results Coming Up

Pharmaceutical and biotech companies generally must endure the lengthy process that is getting their drug candidates to market through clinical trials. There is a fair amount to a great amount ...
Read Full Story »
Test tubes

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the May 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
automatic inspection machine

PDL’s Next Acquisition Target Focus Is on Hypertension

PDL BioPharma Inc. (NASDAQ: PDLI) has now shown where its next revenue stream will be coming from. The company announced on Tuesday that it has committed to an equity investment ...
Read Full Story »
IPO

Selecta Biosciences Files for IPO: Targeting Gout

Selecta Biosciences has filed its paperwork with the Securities and Exchange Commission to conduct an initial public offering (IPO) ahead. The company applied to list its common stock on The ...
Read Full Story »
biotech word cloud

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Investors have had a hard time in May. Biotech investors also have faced some hard decisions going into the 2016 elections, where both sides of the aisle seem more than willing ...
Read Full Story »
Target

4 Companies That Destroyed Shareholders This Past Week

Earnings season is practically over. The analysts that were expecting earnings disappointments for this season appear to have been correct as many companies have fallen flat in the past few ...
Read Full Story »
graph

8 Stocks on the Move After ASCO Cancer Abstracts

The American Society of Clinical Oncology (ASCO) is in the process of setting up for its annual meeting in Chicago. In this meeting, companies and cancer drug developers will share ...
Read Full Story »
dominoes collapsing

Is This the Beginning of the End of Aduro BioTech?

Aduro BioTech Inc. (NASDAQ: ADRO) watched its shares tumble on Monday morning following negative results in its mid-stage ECLIPSE trial. The company announced that the Phase 2b ECLIPSE trial did ...
Read Full Story »
child with cancer

ASCO Could Make or Break These 7 Cancer Drug Trials

It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ...
Read Full Story »